From start-ups to leading global companies, Greater Fort Lauderdale provides a stimulating and supportive business environment for success in the life sciences.

Eli Lilly

Merck halts Alzheimer’s phase 3 after interim data analysis

Lilly to ax 200 R&D positions globally

Lilly buys migraine biotech CoLucid, and the drug it outlicensed, for $960M

After phase 3 failures, Lilly signs new Alzheimer’s drug pact with AstraZeneca

Analysts on amyloid thesis: It's not dead yet